| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70578 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
1999-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2001-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1067194-A1 |
| titleOfInvention |
Vectors containing a gene coding for CD40 and/or CD40L under the control of a cytokine-inducible promoter which is a human acute phase amyloid A gene promoter. Methods for their production and uses thereof |
| abstract |
A vector for the expression of a nucleic acid encoding at least onenpolypeptide with CD40 and/or CD154 activity, wherein the expression ofnsaid nucleic acid is under the control of a cytokine-inducible promotor,nis preferably administered locally to solid tumors for tumor therapy,nwherein the promotor is a human acute phase amyloid A gene promotor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7569338-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7368546-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7214512-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7455846-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964400-B2 |
| priorityDate |
1999-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |